EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis

Simon Licht-Mayer, Graham R Campbell, Arpan R Mehta, Katie McGill, Alex Symonds, Sarah Al-Azki, Gareth Pryce, Stephanie Zandee iD, Chao Zhao, Markus Kipp, Kenneth J Smith, David Baker und 11 weitere

Neuropathology and Applied Neurobiology · 2023-02 · 49 (1)

DOI: 10.1111/nan.12851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 07.10.2022. Verfasst von Simon Licht-Mayer und 22 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Multiple Sclerosis, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Motor Neurone Disease Association, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Axonal injury in multiple sclerosis (MS) and experimental models is most frequently detected in acutely demyelinating lesions. We recently reported a compensatory neuronal response, where mitochondria move to the acutely demyelinated axon and increase the mitochondrial content following lysolecithin‐induced demyelination. We termed this homeostatic phenomenon, which is also evident in MS, the axonal response of mitochondria to demyelination (ARMD). The aim of this study is to determine whether ARMD is consistently evident in experimental demyelination and how its perturbation relates to axonal injury.

Methods

In the present study, we assessed axonal mitochondrial content as well as axonal mitochondrial respiratory chain complex IV activity (cytochrome c oxidase or COX) of axons and related these to axonal injury in nine different experimental disease models. We used immunofluorescent histochemistry as well as sequential COX histochemistry followed by immunofluorescent labelling of mitochondria and axons.

Results

We found ARMD a consistent and robust phenomenon in all experimental disease models. The increase in mitochondrial content within demyelinated axons, however, was not always accompanied by a proportionate increase in complex IV activity, particularly in highly inflammatory models such as experimental autoimmune encephalomyelitis (EAE). Axonal complex IV activity inversely correlated with the extent of axonal injury in experimental disease models.

Conclusions

Our findings indicate that ARMD is a consistent and prominent feature and emphasise the importance of complex IV activity in the context of ARMD, especially in autoimmune inflammatory demyelination, paving the way for the development of novel neuroprotective therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisEncephalomyelitis, Autoimmune, ExperimentalAnimalsAxonsNeuronsMitochondria

Stichwörter der Autor:innen

axon injurycomplex IVexperimental demyelinationmitochondriamultiple sclerosis and neuroprotection

Autor:innen und Institutionen

  • Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
  • Wellcome Trust-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
  • Institute of Anatomy, Rostock University Medical Center, Rostock, Germany.

ORCID-Profile: Stephanie Zandee, Hans Lassmann

Förderung

  • Medical Research Council
  • Motor Neurone Disease Association
  • NINDS NIH HHS
  • Multiple Sclerosis Society
  • National Multiple Sclerosis Society
  • Korea National Institute of Health
  • International Progressive MS Alliance

Zitieren

APA

Licht-Mayer, S., Campbell, G. R., Mehta, A. R., McGill, K., Symonds, A., Al-Azki, S., Pryce, G., Zandee, S., Zhao, C., Kipp, M., Smith, K. J., Baker, D., Altmann, D., Anderton, S. M., Kap, Y. S., Laman, J. D., 't Hart, B. A., Rodriguez, M., Franklin, R. J. M., …, & Mahad, D. J. (2023). Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis. Neuropathology and Applied Neurobiology, 49(1). https://doi.org/10.1111/nan.12851

Vancouver

Licht-Mayer S, Campbell GR, Mehta AR, McGill K, Symonds A, Al-Azki S, et al. Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis. Neuropathology and Applied Neurobiology. 2023;49(1). doi:10.1111/nan.12851

BibTeX
@article{LichtMayer2023,
  author = {Licht-Mayer, Simon and Campbell, Graham R and Mehta, Arpan R and McGill, Katie and Symonds, Alex and Al-Azki, Sarah and Pryce, Gareth and Zandee, Stephanie and Zhao, Chao and Kipp, Markus and Smith, Kenneth J and Baker, David and Altmann, Daniel and Anderton, Stephen M and Kap, Yolanda S and Laman, Jon D and 't Hart, Bert A and Rodriguez, Moses and Franklin, Robin J M and Chandran, Siddharthan and Lassmann, Hans and Trapp, Bruce D and Mahad, Don J},
  title = {Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2023},
  volume = {49},
  number = {1},
  doi = {10.1111/nan.12851}
}
Kostenlos starten →